Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2006-002726-32-IT
EUCTR2006-002726-32-IT
Active, not recruiting
Not Applicable

PROtection of coronary Microcirculation by Iloprost:Safety and Efficacy evaluation in PCI - PROMISE

AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI0 sitesSeptember 14, 2007
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionscoronary angioplastyMedDRA version: 9.1Level: LLTClassification code 10050329Term: Coronary angioplasty
DrugsENDOPROST 50*INFUS 1F 0,050MG/

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
coronary angioplasty
Sponsor
AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
Status
Active, not recruiting
Last Updated
14 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 14, 2007
End Date
TBD
Last Updated
14 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI

Eligibility Criteria

Inclusion Criteria

  • •Indication to elective coronary angioplasty
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) yes
  • •F.1\.2\.1 Number of subjects for this age range
  • •F.1\.3 Elderly (\>\=65 years) yes
  • •F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • •Complete block of left branch
  • •Previous myocardial infarct
  • •Arterial Hypertension (\> 180/100 mmHg)
  • •Pregnancy or fruitful age

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Not Applicable
PROtection of coronary Microcirculation by Iloprost:Safety and Efficacy in Percutaneous Coronary Intervention - PROMISE PCI
EUCTR2008-001319-39-ITAZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
Active, not recruiting
Phase 1
Protective effect of antiplatelet drug Ticagrelor compared to antiplatelet drug Clopidogrel on small heart vessels in diabetic patient with anginaIschemic Heart Disease in Diabetic patientsMedDRA version: 18.1 Level: PT Classification code 10072685 Term: Microvascular coronary artery disease System Organ Class: 10007541 - Cardiac disordersTherapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
EUCTR2015-003621-33-ESFundación Interhospitalaria de Investigación Cardiovascular50
Active, not recruiting
Not Applicable
Influence on the coronary Microcirculation and on myocArdial perfusion Reserve of Niaspan given IN addition to simvastatin in diabEtic patients - MARINE
EUCTR2006-000569-13-DECardioangiologisches Centrum Bethanien40
Active, not recruiting
Not Applicable
PROMISE AMI (PROtection of coronary Microcirculation by Iloprost: Safety and Efficacy evaluation in Acute Myocardial Infarction treated by primary PCI) Pilot Study - Promise AMI
EUCTR2008-001325-34-ITAZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
Completed
Not Applicable
Coronary Microcirculatory and Bioresorbable Vascular ScaffoldsCHD - Coronary Heart DiseaseAngina, StableMyocardial Ischemia
NCT03076476Papworth Hospital NHS Foundation Trust36